Welcome to Lamellar Biomedical

Lamellar is developing a range of patent protected medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. Diseases which may benefit from the application of Lamellasome™ mimetics of the body’s lamellar bodies include Dry Mouth, Dry Eye and Cystic Fibrosis.

Learn more

Research & Development

Lamellar in partnership with clinical centres-of-excellence is highly advanced in developing novel products for Dry Mouth, Dry Eye and Cystic Fibrosis.

Learn more

Investors

Lamellar Biomedical Shareholders comprise both institutional and private investors.

Learn more

News & Press

What has been going on at Lamellar?

Learn more

Lamellar Biomedical

An innovative, biotechnology company bringing new patent protected medical devices and pharmaceutical products to the healthcare market.

Strategic Goals

To successfully develop and commercialise multiple medical devices and pharmaceuticals based on Lamellar’s proprietary Lamellasome™ technology.

Product pipeline

Lamellar's patented Lamellasome™ technology has the ability play an important role in treating a broad range of poorly served medical conditions.